Analysis
Upcoming Elections in Sweden: Will the Far Right Come to Power?
The elections in Sweden have turned into a tight competition, and there is a possibility of the far right entering the g...
Analysis
Analysis
Has Friedrich Merz Lost the Last Chance for Democracy?
The recent victory of the far-right party Alternative für Deutschland in Germany has raised alarm bells and appears conc...
Analysis
Fire on Saudi Oil Pipeline: Dangerous Developments in the Persian Gulf
A key oil pipeline in Saudi Arabia has been set ablaze amid increasing attacks in the region. At the same time, Houthi f...
Analysis
Long War Between Iran and the United States: Neither Side is Retreating
Iran and the United States are preparing for a long war, and there seems to be no sign of a ceasefire in the near future...
Analysis
Iran's Foreign Ministry Spokesperson's Strong Reaction to the Use of 9/11 Attacks to Justify War
With rising tensions in the Middle East, the spokesperson for Iran's Foreign Ministry reacted strongly to statements mad...
Analysis
Crucial Meeting of Iran and Gulf States in Oman
The meeting between Iran and the Gulf countries on September 14 in Oman will address maritime security and navigation ro...
Analysis
Drone Attacks from Iraq on Saudi Oil Pipeline: Tensions in the Middle East Reach Their Peak
Saudi Arabia announced that drones from Iraq have attacked the East-West pipeline, causing its shutdown. This attack occ...
Analysis
New Tensions: Iran and America's Retaliatory Attacks on the Global Stage
The exchange of attacks between Iran and the United States has once again escalated tensions in the Middle East. This co...
Analysis
Intellia Therapeutics Secures $400 Million Funding; Is This Cost Worth It?
Intellia Therapeutics has taken a significant step in developing its products with the new funding. But are these heavy...
Analysis
USA Rare Earth: Can it overcome debt and increase production?
USA Rare Earth has entered the challenging world of production and debt with the acquisition of Serra Verde. Will this c...
Analysis
Royalty Pharma: Can value protection offset the phase 3 failure of Pelacarsen?
The phase 3 failure of the Pelacarsen trial has raised many questions about the future of Royalty Pharma. Can the compan...
Analysis
Extraordinary Growth of GitLab: Will AI Demand Turn into Sustainable Revenue?
GitLab has experienced over 40% annual growth in its annual recurring revenue, but its operating cash flow is negative....